Skip to Content
  • Title
    Group Worldwide Chair
  • Affiliation
    Johnson & Johnson
  • Age
    58

Peterson has expanded her reach at the world’s largest health care company, adding medical devices to a portfolio that includes brands ranging from Band-Aid to Tylenol. She now oversees some $40 billion in revenue—more than half of J&J’s total. She’s been on an acquisition tear, shepherding six deals in the consumer business in the past 18 months and 23 in medical devices during the first half of 2017. The moves are meant to help transform J&J, whose stock has underperformed the S&P over the past 12 months.

Read our July 2016 feature “Can Big Still Be Beautiful?” for more on how Peterson is helping to transform Johnson & Johnson.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Personal Information

Previous Rank27
Newcomer?-

Company Financials (2016, or most recently completed fiscal year)

Revenues ($M)71,890
Profits ($M)16,540
Market Value as of 9/14/17 ($M)
360139.1